US OptionsDetailed Quotes
JNJ240719C147000
- 9.45
- -0.35-3.57%
15min DelayClose Jul 18 16:00 ET
9.90High9.20Low
9.20Open9.80Pre Close7 Volume1.37K Open Interest147.00Strike Price6.54KTurnover0.00%IV0.66%PremiumJul 19, 2024Expiry Date8.42Intrinsic Value100Multiplier0DDays to Expiry1.03Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma18.56Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Johnson & Johnson Stock Discussion
US stock futures edged higher as the recent downturn in chip stocks started to stabilize, boosting investor sentiment. The market is on edge, anticipating more earnings reports to gauge the health of various sectors.
Market Performance and Key Drivers
1. $Dow Jones Industrial Average(.DJI.US)$ and $S&P 500 Index(.SPX.US)$: The $Dow Jones Industrial Average(.DJI.US)$ closed down 1.29%, driven by ...
Solid growth, particularly in the No. 1 category
Johnson & Johnson revealed that its second-quarter sales came in at slightly over $22.4 bi...
$Dow Jones Industrial Average(.DJI.US)$ rose by 0.59% to a new record high, closing at 41,211.12. In contrast, the $S&P 500 Index(.SPX.US)$ fell by 1.39%, and the $Nasdaq Composite Index(.IXIC.US)$ dropped by 2.76%. Tech stocks faced significant pressure, contributing to the mixed market performance.
Key Drivers
1. Strong Performers: $UnitedHealth(UNH.US)$, $Johnson & Johnson(JNJ.US)$, and $Cisco(CSCO.US)$ l...
The tech-heavy Nasdaq ended the day with a 2.7% decline as investors pulled out their money from the tech industry and moved to other sectors.
Specifically, information technology and communication services were the two worst performing sectors when session ended. Dow Jones rose about 0.6%
$Invesco QQQ Trust(QQQ.US)$ $Dow Jones Industrial Average(.DJI.US)$ $Apple(AAPL.US)$ $Tesla(TSLA.US)$ $NVIDIA(NVDA.US)$ $Alphabet-A(GOOGL.US)$ $Amazon(AMZN.US)$ $Netflix(NFLX.US)$ $Meta Platforms(META.US)$ $Johnson & Johnson(JNJ.US)$ $Super Micro Computer(SMCI.US)$ $Advanced Micro Devices(AMD.US)$ $Palantir(PLTR.US)$
Gapping up
$Johnson & Johnson(JNJ.US)$ The healthcare giant's stock rose by less than 1% after it reported a strong second quarter, with earnings and revenue exceeding Wall Street's expectations. The company posted adjusted EPS of $2.82, beating analysts' predictions by $0.10, and revenue of $22.45 billion, surpassing the consensus estimate of $22.34 billion.
$adidas AG(ADDYY.US)$ climbed on Wednesday as the Ger...
This broadening market rally is underway as traders have become more optimistic on interest rate cuts, which should benefit small caps and companies wi...
No comment yet